Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik 

Slides:



Advertisements
Similar presentations
Presented by: Oyeyemi Ajayi, Prashant Kuntala, and Colin Kruse
Advertisements

Box H/ACA Small Ribonucleoproteins
Yuming Lu, Jian-Kang Zhu  Molecular Plant 
Volume 22, Issue 7, Pages (July 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Genome-editing Technologies for Gene and Cell Therapy
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Volume 62, Issue 2, Pages (April 2016)
Figure 2 Use of CRISPR/Cas9 for genome editing
CHIPping Away at Base Excision Repair
Erik D. Larson, W. Jason Cummings, David W. Bednarski, Nancy Maizels 
Origin of Chromosomal Translocations in Lymphoid Cancer
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
RNA Processing and Genome Stability: Cause and Consequence
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 7, Issue 1, Pages (April 2014)
Eukaryotic Transcription Activation: Right on Target
Molecular Therapy - Nucleic Acids
Volume 13, Issue 6, Pages (December 2013)
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
Volume 164, Issue 1, Pages (January 2016)
ATM Creates a Veil of Transcriptional Silence
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Xiaoyu Chen, Jin Liu, Josephine M. Janssen, Manuel A.F.V. Gonçalves 
Volume 154, Issue 6, Pages (September 2013)
Michael A. Kohanski, Mark A. DePristo, James J. Collins  Molecular Cell 
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Paradigms for the Three Rs: DNA Replication, Recombination, and Repair
Volume 63, Issue 4, Pages (August 2016)
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Genome-editing Technologies for Gene and Cell Therapy
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Somatic Hypermutation of Immunoglobulin Genes
Volume 10, Issue 2, Pages (February 2018)
Volume 11, Issue 6, Pages (May 2015)
CRISPR-Mediated Base Editing without DNA Double-Strand Breaks
Volume 49, Issue 1, Pages 1-3 (January 2013)
Translocation Mapping Exposes the Risky Lifestyle of B Cells
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Regulatory RNAs in Bacteria
Nadja Heidrich, Jörg Vogel  Molecular Cell 
Box H/ACA Small Ribonucleoproteins
The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies  Zhonghui Luo, MS, Diana Ronai,
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Andres Canela, Andre Stanlie, André Nussenzweig  Molecular Cell 
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Functional and Mechanistic Diversity of Distal Transcription Enhancers
Volume 17, Issue 2, Pages (August 2015)
Division of Labor at the Eukaryotic Replication Fork
Volume 16, Issue 2, Pages (February 2015)
At Loose Ends: Resecting a Double-Strand Break
Irina Artsimovitch, Georgi A. Belogurov  Molecular Cell 
Volume 41, Issue 2, Pages (January 2011)
Genome-wide “Re”-Modeling of Nucleosome Positions
Michael J. McIlwraith, Stephen C. West  Molecular Cell 
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
CRISPR in Parasitology: Not Exactly Cut and Dried!
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
CRISPR Immunological Memory Requires a Host Factor for Specificity
CRISPR Craze to Transform Cardiac Biology
Volume 25, Issue 4, Pages e3 (October 2018)
Volume 10, Issue 2, Pages (February 2018)
Presentation transcript:

Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes  Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik  Molecular Cell  Volume 68, Issue 1, Pages 26-43 (October 2017) DOI: 10.1016/j.molcel.2017.09.029 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Molecular Components and Mechanisms for Base Editing (A) The molecular components of the base editor (BE), Target-AID, Targeted AID-mediated Mutagenesis (TAM), and CRISPR-X technologies are shown. The BE3, YEE-BE3, and Target-AID systems employ the Cas9 D10A (purple) nickase along with a cytidine deaminase (red) and a uracil DNA glycosylase inhibitor (yellow). The BE4 system also uses the Gam protein (pink). The TAM and CRISPR-X systems used dCas9 (green) to recruit variants of the deaminase AID (AIDx or MS2-AID∗Δ). Below each technology, the targeting window is indicated. The increased spectrum of base substitutions that can be achieved with TAM and CRISPR-X is represented by the multi-color editing windows. (B) For base editors, the mechanisms of DNA repair are critical for the eventual editing outcome. After the initial deamination (C to U) conversion, uracil DNA glycosylase can remove the base and perform error-free (correctly replacing U with C) or error-prone repair, generating different substitutions (left side). Alternatively, a uracil DNA glycosylase inhibitor (UGI) can be used to block base excision by uracil N-glycosidase (UNG). Nicking via a Cas9 nickase of the non-deaminated strand promotes long-patch BER where the deaminated strand is preferred for templated repair, generating a U:A base pair that is then resolved as a T:A base pair. Upon formation of the abasic site, an AP lyase can remove the site, forming a ssDNA break. This excision in conjunction with the Cas9 D10A can create a DSB. Addition of the bacteriophage protein Gam reduces the frequency of indel formation by directly binding the DSB, which may select against cells with DSBs. Endogenous repair machinery is labeled in black and represented with black triangles. Exogenous components of the base-editing tools are illustrated and labeled in color. Molecular Cell 2017 68, 26-43DOI: (10.1016/j.molcel.2017.09.029) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Applications of Base-Editing Technologies Base editing has been applied in two main areas: precision editing and screening applications. (A) For precision editing, corrective or beneficial conversion of cytidines to thymidines has been demonstrated in many systems. Multiple delivery targets and methods that have been used are shown (see also Table 1). Precision editing has also been used for agricultural engineering using agrobacterium or biolistic DNA particle bombardment to deliver base editors to tomato, maize, wheat, and rice plants. (B) Diversifying base editors have been used to evolve and study protein function and structure. In these experiments, sgRNAs tiling a region are used to generate targeted mutations, and the subsequent population of variants is screened for specific phenotypes (i.e., drug resistance/fluorescence), followed by targeted sequencing of the locus. To validate identified mutations, enriched variants are individually installed, and drug resistance or the activity of the individual clones is validated. (C) The precise base-editing system can also be used for screening applications. Targeting the BE3 system to Arg, Gln, and Trp codons can edit each into stop codons, generating truncated gene products (CRISPR-STOP, iSTOP). This platform provides a potential alternative to Cas9 gene screens without inducing double-strand breaks. Molecular Cell 2017 68, 26-43DOI: (10.1016/j.molcel.2017.09.029) Copyright © 2017 Elsevier Inc. Terms and Conditions